Stay updated on QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.

Latest updates to the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page
- Check7 days agoChange DetectedThe footer revision label changed from v3.7.1 to v3.7.2; the study record remains unavailable on the 403 error page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe footer’s site revision changed from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page now shows a 403 Forbidden error, replacing the study details with a basic error screen and a revision note.SummaryDifference18%

- Check56 days agoChange DetectedThe Revision line now shows v3.6.6, replacing v3.6.5. This indicates a small software update to the page’s underlying system.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a minor update to the study details page (likely small content corrections or layout tweaks) without changing the core study information.SummaryDifference0.0%

- Check92 days agoChange DetectedRevision history now lists a new revision v3.6.4 and removes the previous v3.6.3 entry, indicating a minor update to the page's versioning. This does not alter the study details or user-facing content.SummaryDifference0.0%

Stay in the know with updates to QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the QUADRA Study of Niraparib in Ovarian Cancer Clinical Trial page.